Verinata Health
E474921
Verinata Health is a biotechnology company specializing in non-invasive prenatal genetic testing and diagnostics.
Statements (40)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology company
ⓘ
medical diagnostics company ⓘ |
| acquiredBy | Illumina NERFINISHED ⓘ |
| acquisitionYear | 2013 ⓘ |
| basedIn | Redwood City, California NERFINISHED ⓘ |
| businessModel | clinical laboratory testing services ⓘ |
| countryOfOrigin |
United States of America
ⓘ
surface form:
United States
|
| field |
molecular diagnostics
ⓘ
prenatal genetics ⓘ |
| focusesOn |
Down syndrome screening
ⓘ
aneuploidy screening ⓘ cell-free fetal DNA testing ⓘ trisomy 13 screening ⓘ trisomy 18 screening ⓘ |
| hasAreaOfResearch |
genomic medicine
ⓘ
non-invasive prenatal diagnostics ⓘ |
| industry |
biotechnology
ⓘ
prenatal diagnostics ⓘ |
| isSubsidiaryOf | Illumina NERFINISHED ⓘ |
| locatedIn |
California, United States
ⓘ
surface form:
California
United States of America ⓘ
surface form:
United States
|
| market |
genetic testing services
ⓘ
prenatal care ⓘ |
| method | analysis of fetal DNA in maternal plasma ⓘ |
| offers |
laboratory-developed tests
ⓘ
non-invasive prenatal tests for chromosomal abnormalities ⓘ |
| operatesAs | wholly owned subsidiary of Illumina ⓘ |
| parentCompany | Illumina NERFINISHED ⓘ |
| purpose | early detection of fetal chromosomal abnormalities ⓘ |
| regulatoryStatus | clinical laboratory service provider ⓘ |
| sampleType | maternal blood ⓘ |
| specializesIn |
non-invasive prenatal testing
ⓘ
prenatal genetic diagnostics ⓘ |
| targetCustomers |
maternal-fetal medicine specialists
ⓘ
obstetricians ⓘ pregnant patients ⓘ |
| testType | screening test ⓘ |
| usesApproach | high-throughput DNA sequencing ⓘ |
| usesTechnology |
cell-free DNA analysis
ⓘ
next-generation sequencing ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.